Interstitial Lung Diseases (ILD), including but not limited to idiopathic pulmonary fibrosis (IPF) research hub

Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis

This study is testing a new way to give an existing medicine, pirfenidone, using an inhaler. It's for people with certain lung conditions like Idiopathic Pulmonary Fibrosis (IPF). We want to see if this inhaled version is safe and whether it causes side effects.